Skip to main content

Media

Latest News

July 26, 2018

Today, Congressman Kevin McCarthy, Co-Chairman of the Congressional Valley Fever Task Force, introduced H.R. 6562, the bipartisan FORWARD Act with fellow Co-Chairman Congressman David Schweikert (AZ-6) and Task Force Members Congresswoman Martha McSally (AZ-2), Congresswoman Karen Bass (CA-37), and Congresswoman Kyrsten Sinema (AZ-9). This legislation would strengthen research and help advance treatment and vaccine development for Coccidioidomycosis, commonly known as Valley Fever, as well as other orphan endemic fungal diseases.


May 4, 2018

Today, Congressman McCarthy, as Co-Chair of the Congressional Valley Fever Task Force, along with 16 of his colleagues in the House, sent a letter to National Institutes of Health (NIH) Director Francis Collins in support of grant funding to help move a Valley Fever diagnostic tool into primary care settings, such as the family doctor's office. Currently, Immuno-Mycologics, Inc. (IMMY) has a rapid diagnostic tool, which consists of a dipstick test to detect the presence of Valley Fever antibodies in human blood in as little as 30 minutes.


July 17, 2017
Viamet Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to VT-1598, a novel oral agent for the treatment of coccidioidomycosis, also known as Valley Fever.

June 15, 2017
Valley Fever is a disease you can catch from the dust in the air. Many cases are mild but some can be so severe they attack skin and bone and threaten your life.